Here we show that it has acquired the ability to target multiple viruses by evolving an active site that interconverts between multiple conformations. Mutations that have relieved active site constraints allow RhTC to dynamically sample conformational space, including radically different conformers that target both HIV-1 and HIV-2 viruses. Introduction of a reversible constraint into RhTC allows specificity to be switched between a single conformation specific for HIV-1 and a dynamic ensemble that targets multiple viruses. These results show that conformational diversity can be used to expand the target diversity of innate immune receptors by supplementing their limited genetic variability with variability in protein structure.
A successful immune response depends upon successful pathogen detection. This is a major challenge, as the diversity of pathogen mole cules is almost limitless. Furthermore, successful detection places the pathogen under selection pressure to evolve a variant molecule that escapes recognition. The result is a constant evolutionary struggle between host and pathogen as each continually adapts to achieve an advantage. However, pathogens have an apparent advantage over their hosts in that they evolve far more rapidly. Moreover, innate antiviral proteins, such as TRIM5α (ref. 1) and TRIMCyp 2, 3 , that directly bind and restrict the replication of lentiviruses, such as HIV, have a fixed specificity within the lifetime of an individual. How these proteins target rapidly evolving and diverse viruses is unclear.
Recently, we described the structure of RhTC and showed how two mutations in its cyclophilin domain have remodeled its active site to allow it to bind HIV2 (ref. 4) . However, RhTC has been shown to target and restrict multiple diverse lentiviruses in addition to HIV2, including HIV1 O group, SIVagm and FIV 5 . If the active site has been remodeled to bind HIV2, how does RhTC target these other viruses? Cyclophilin A (CypA) has a single conformation and can functionally interact only with HIV1 and not with HIV2. Therefore, we reasoned that the mutations affecting RhTC may have made its active site conformationally dynamic, such that, instead of adopting a single conformation specific to HIV2, it isomerizes between multiple conformations that can target multiple viruses. To test this hypothesis, we used a combination of Xray crystallography, NMR dynamics, isothermal titration calorimetry and protein engineering studies.
Here we have shown that the active site of RhTC is in a state of conformational flux, allowing it to rapidly sample multiple conforma tions. Furthermore, the data suggest that these multiple conformations are functional and are used by RhTC to target multiple viruses. Finally, we have incorporated a reversible constraint into RhTC that allowed us to switch it between a single conformation that can target only HIV1 and a dynamic state that can target multiple viruses. These results illustrate how conformational diversity can be exploited by hosts to target multiple viral strains.
RESULTS

RhTC targets different viruses with different conformations
RhTC evolved from a duplicated CypA gene that retrotransposed into the TRIM5 locus 3 . CypA efficiently binds to the capsid of HIV1 but not HIV2; yet RhTC restricts both viruses. Two mutations (relative to CypA) in the portion of the gene encoding the cyclophilin domain of RhTC (unless stated otherwise, this domain will henceforth be referred to as "RhTC"). D66N and R69H confer binding to the HIV2 capsid protein, while maintaining binding to the HIV1 Ogroup capsid protein; these mutations were found to result in a new active site conformation 4 . However, it was not clear how this new conforma tion gives rise to HIV2 binding or how binding to HIV1 O group is simultaneously maintained, especially given the shift away from the conformation found in CypA that is known to be required for binding HIV2 capsid protein.
HIV capsids have been shown to interact with CypA using residues solely within the cyclophilinbinding loop 6 . It has also been shown that binding can be recapitulated by a linear peptide consisting purely of cyclophilinbinding loop 7 and that binding and specificity can be transferred by transplanting the cyclophilinbinding loop from one virus onto the capsid of another 8, 9 . To understand the structural basis of RhTC dual targeting, we determined crystal structures of the RhTC (Fig. 1a and Table 1 ). In the RhTC-HIV2 complex, the active site of RhTC adopted a very similar conformation to the previously solved structure of free RhTC ( Fig. 1b; PDB 2WLW ). In particular, loop [66] [67] [68] [69] [70] [71] [72] [73] [74] formed an extended open βzipper structure that differed substantially from its confor mation in CypA. This conformation was the result of very large main chain rearrangements of >15 Å. The extension of loop 66-74 allowed the rearrangement of key residues with respect to CypA, such as Arg55, that could now make a stacking interaction with the Pro86Gly87 peptide bond in HIV2 capsid protein.
Next, we compared the conformation of RhTC in the HIV2 complex to its confor mation in the HIV1 Ogroup complex and found that there were substantial differences. In particular, in the Ogroup complex, RhTC did not have an extended loop 66-74 βzipper structure; instead, the loop doubled back after residue Phe67 (Fig. 1b) . In this respect, RhTC in the HIV1 Ogroup complex was more similar to the closed conformation of CypA in its complex with the same Ogroup capsid (PDB 1M9D) ( Fig. 1b; ref. 10 ). However, there was evidence that loop [66] [67] [68] [69] [70] [71] [72] [73] [74] in RhTC was more flexible than in CypA. The B fac tors for RhTC loop 66-74 are higher than in the scaffold, and residues 70 and 71 have been omitted because of incomplete density (Supplementary Figs. 1 and 2) . Therefore, we hypothesized that RhTC could bind both HIV2 and HIV1 Ogroup viruses because the two mutations, D66N and R69H, had increased the flexibility of loop [66] [67] [68] [69] [70] [71] [72] [73] [74] , unconstraining it from a single fixed conforma tion. Furthermore, we reasoned that the crystal structures might have shown just two of a large number of possible RhTC conformations.
The RhTC binding loop is highly mobile
To test our hypothesis that loop [66] [67] [68] [69] [70] [71] [72] [73] [74] of RhTC has evolved to become conformationally dynamic, we examined its structure in solution using 15 N backbone relaxation NMR experiments and compared it to CypA (Fig. 2a) . 15 a Numbers in parentheses represent the value in the highest-resolution shell. Each data set was collected from a single crystal. npg a r t i c l e s in detail 11 , and our data for CypA and RhTC were in broad agree ment with previous studies. On the basis of averaged 15 N T 2 relaxa tion times and { 1 H} 15 N NOE ratios for residues in defined secondary structure elements, both proteins had similar overall tumbling rates and internal dynamics (Fig. 2a) . However, the two point mutations D66N and R69H resulted in major differences within loop [66] [67] [68] [69] [70] [71] [72] [73] [74] . In CypA, loop 66-74 decreased apparent 15 N T 2 relaxation times as a result of conformational exchange contributions on a micro to millisecond timescale ( Fig. 2a; ref. 12). Chemical exchange did not contribute to the intrinsic backbone dynamics and was therefore not observed in the { 1 H} 15 N NOE data ( Fig. 2a) . Analysis of the free CypA crystal struc ture showed that loop 66-74 was tethered at each end by a doubleglycine motif (GGXXXXXXXXGG), whereas the loop itself was tightly con strained by a network of hydrogen bond interactions mediated by the side chain of Asp66 (Fig. 2b) . This suggested that the origin of slow conformational exchange processes in CypA was segmental motions of loop 66-74 as it pivoted around the doubleglycine repeats. In contrast to those for CypA, the 15 N T 2 relaxation times for loop 66-74 in RhTC were substantially increased (Fig. 2a , bottom right), indicat ing high flexibility in particular for residues Thr68, His70, Asn71 and Gly74. This coincided with a decrease in { 1 H} 15 N NOE ratios (Fig. 2a) , giving values associated with highly dynamic regions 13 . Both experi ments revealed a substantial change in the mobility of loop 66-74 from slow segmental motion on a micro to millisecond timescale to fast quasiindividual mobility on a picosecond timescale. The residues (68-74) that underwent this change in timescale of motion were those whose main chain atoms formed a hydrogen bond network with the side chain of Asp66 in CypA (Fig. 2a) . However, the RhTC crystal structure showed that because of the change of Asp66 to Asn66, this hydrogen bond network was lost and residues 68-74 were no longer centrally coordinated or constrained to move as a single unit (Fig. 2b,c) . Together, the NMR and crystallographic data indicated that a loss of loop constraints in RhTC led to a gain of dynamics.
To further study how loop dynamics were altered in RhTC, we used relaxation dispersion methods to understand and define the timescale of loop residue motions. Relaxation dispersion measurements dis sect contributions to the apparent transverse relaxation rates R 2 app (1/T 2 app) into two components: (i) the intrinsic transverse relaxation rate (R 2 intr) as determined by the overall tumbling of a protein and its fast internal (picosecond) mobility and (ii) the chemical exchange contribution (R ex ), which is a measure of exchange between two or multiple states on a timescale slower than the overall correlation time (τ c ) of the protein (typically on a micro to millisecond time scale). The application of increasing spinlock fields (ν CPMG ) during a constant time (T 2 ) experiment leads to an attenuation of chemical exchange contributions, which in the ideal case of an infinitely strong spinlock field provides a measure of the intrinsic R 2 int r rates. The spinlockdependent rate of attenuation is therefore a direct measure of the timescale of exchange processes present.
In agreement with published data 12 , we found that CypA residues 67, 68, 72, 74 and 77, but not 76 and 78, underwent conformational exchange ( Fig. 3 and Supplementary Table 1) . Global fitting using NESSY resulted in exchange values (k ex ) similar to those published for group II residues 65-84 (ref. 14) . No attenuation was observed for the corresponding residues in RhTC, although the residues in the stem region at either end of the loop (62-66 and 79-80) had similar dynamic properties. The differences in loop 66-74 dynamics between CypA and RhTC were therefore confined to specific residues at the loop apex that are constrained in CypA and unconstrained in RhTC (Figs. 2a,b and 3) . The heteronuclear { 1 H} 15 N NOE and T 2 data indicated that these residues underwent fast picoseconds reorientations; however, the pos sibility that this was superposed on an underlying largescale loop motion with a slow timescale could not be excluded. The existence of simultaneous slow and fast conformational motion has recently been demonstrated 14 . The fact that RhTC has both the flexible double glycine 'hinge' found in CypA and additional freedom of motion supplied by the D66N mutation would support a similar conclusion.
Stabilizing a single structure forces a single specificity
The data showed that RhTC has evolved mutations that have made its active site dynamic. Next, we investigated whether this property of dynamics enables RhTC to bind multiple viruses. To test this, we determined whether different conformations confer binding to the HIV1 O group and HIV2 and whether by constraining loop 66-74 into a single conformation we could make RhTC specific to a single virus. npg a r t i c l e s A 'conformational trap' strategy was used to lock RhTC into a single conformation through a disulfide bridge. RhTC contains a cysteine residue at position 52, which was in proximity to His70 when loop 66-74 adopted a closed conformation as observed in CypA and the RhTC-HIV1 Ogroup complex (CαCα separation of ~7.5 Å). Conversely, in the open conformation seen in the RhTC-HIV2 complex these two residues remained >18 Å apart. Taking advantage of this differ ence, we mutated His70 to cysteine so that if the closed conformation were populated in the free state it would become trapped through a disulfide bridge, preventing isomerization to the open conformation. We then tested our prediction that locking the closed conformation in place would prevent HIV2 capsid protein binding but maintain binding to HIV1 Ogroup capsid protein by isothermal titration calorimetry (ITC) and Xray crystallography (Fig. 4) . ITC showed that RhTC H70C lost the ability to bind HIV2 and could only bind HIV1 Ogroup capsid. The structure of RhTC H70C in complex with HIV1 Ogroup capsid confirmed that this was because loop [66] [67] [68] [69] [70] [71] [72] [73] [74] had been trapped in a closed conformation through the formation of the predicted disulfide bond between Cys52 and Cys70 (Fig. 4a) . The structure also gave independent confirmation that it was indeed the closed loop conformation that bound HIV1 O group, as suggested by the RhTC-Ogroup structure. Fixing the closed loop confirmation in [66] [67] [68] [69] [70] [71] [72] [73] [74] , such that the loop B factors were then similar to the rest of the protein scaffold (Supplementary Fig. 1) . Moreover, residues 70 and 71, for which there was incomplete density in the RhTC-Ogroup structure, could then clearly be seen. The combination of ITC and structure strongly suggested that a closedloop conformation was used to bind HIV1 O group and that an inability to adopt an open conformation, as seen in the RhTC-HIV2 complex, prevented binding to HIV2.
To confirm that it was the inability to adopt an open conformation that prevented RhTC H70C from binding HIV2, we repeated the ITC binding experiments in the presence of DTT. Upon addition of DTT, binding to HIV1 O group was maintained, and binding to HIV2 was recovered (Fig. 4b) . To ensure that addition of DTT reduced the disulfide bridge and that recovery of HIV2 binding was associ ated with the ability to adopt an open conformation, we solved the structure of free RhTC H70C in the presence of DTT. The structure showed that DTT reversed the disulfide bridge and that an open conformation was adopted, explaining why binding could then be seen by ITC (Fig. 4) . Together with the NMR data, this suggested that RhTC is structurally dynamic and capable of adopting function ally distinct conformations.
The NMR data suggested that RhTC does not simply isomerize between open and closed conformations but is highly dynamic, sampling a large number of conformers of which these are merely two extremes. To demonstrate that RhTC could sample other con formers than the open and closed states, we investigated its bind ing to the cyclic 11residue, nonribosomal peptide cyclosporin A. Determination of the crystal structure of RhTC in complex with cylosporin A showed a third active site conformation (Supplementary Fig. 3 ). This structure showed that RhTC is not in equilibrium between two fixed conformations and, together with the NMR, suggested that it instead dynamically samples a range of states. RhTC may access a large volume of conformational space that encompasses radically different open and closed states, but it also adopts conformations in between (Supplementary Fig. 3) . Furthermore, these different states may be functionally relevant and expand binding specificity.
A question arising from the evolution of conformational dynamics in RhTC is whether the increased flexibility is penalized by loss of affinity because of the lower conformational entropy upon bind ing. To address this, we compared the thermodynamics of HIV1 CA Oloop binding to RhTC with RhTC H70C. It might be expected that binding to RhTC (and RhTC H70C in the presence of reducing agent) would occur with a weaker affinity and be more entropically unfavorable due to the greater flexibility in loop [66] [67] [68] [69] [70] [71] [72] [73] [74] . However, our ITC data showed that both affinity and change in entropy (∆S) were similar for HIV1 CA Oloop binding to RhTC (K d = 38.5 µM; T∆S = 1.98 kcal mol -1 ), RhTC H70C (in the presence of DTT, 61.3 µM, 1.59 kcal mol -1 ) and RhTC H70C (in the absence of DTT, 47.8 µM, 2.12 kcal mol -1 ) (Supplementary Fig. 4a and c) . Thus, although there is a theoretical cost to binding affinity associated with increased flexibility, we had no evidence of this in our system. Nonetheless, as ITC measures the total entropy change of the system, it was possible that the entropic cost associated with stabilizing a single protein con formation was offset by the release of solvent molecules.
RhTC targets multiple viruses except HIV-1 M group
To investigate the extent of RhTC specificity, we examined its inter action with capsid proteins from other diverse lentiviruses. Using ITC, we found that RhTC bound feline immunodeficiency virus (FIV) capsid protein and lion lentivirus (LLV) capsid protein ( Supplementary  Fig. 4b,c) , in addition to HIV1 Ogroup capsid protein and HIV2 capsid protein. RhTC binding was conserved to these viruses despite the fact they have very different cyclophilinbinding loops, both in terms of length and amino acid composition (Fig. 5a) . Therefore, RhTC was an effective innate antiviral, capable of binding multiple, diverse targets, despite the fact that it is encoded by a single gene. Notably, RhTC is unable to bind or target HIV1 Mgroup viruses, the strain responsible for the current worldwide AIDS pandemic 15 .
We attempted to explain loss of binding to RhTC with our combined structural, NMR and ITC data. Comparison of the RhTC-Ogroup com plex with the previously solved CypA-Mgroup complex 6 showed that the rigid loop 66-74 conformation found in the CypA structures was not present in RhTC. The rigid conformation of loop 66-74 was critical for HIV1 M binding as correct positioning of the Gly72 peptide oxygen was required for formation of a hydrogen bind with the main chain nitrogen at capsid protein position 88. The loss of this interaction in RhTC may explain why it cannot bind Mgroup virus (Fig. 5b) . Conversely, it is possible that RhTC still bound HIV1 O group because although the hydrogen bond interaction was lost, a compensating interaction was made. The more relaxed loop 66-74 conformation in RhTC resulted in rearrangement of Thr73, generating a new interaction with capsid pro tein through hydrophobic burial of the methionine side chain at position 88. With a highly conserved alanine at position 88, the HIV1 M group escapes this interaction. Mutation of Ala88 to methionine or valine is sufficient to make HIV1 M group susceptible to RhTC whereas the reciprocal mutation allows HIV1 O group to escape 4 . Thus, the same mutation, D66N, which imparted conformational dynamics on RhTC through weakening of the hydrogen bond network holding loop 6674 in place might also be responsible for loss of binding to Mgroup virus.
DISCUSSION
Our data suggest that, during its evolution, RhTC has acquired muta tions that have conferred a property of conformational dynamics. This property allows RhTC to isomerize between radically different active conformations that are used to target different HIV viruses. When RhTC is constrained into a single conformation, only one virus can be bound. Releasing RhTC constraints recovers conformational diversity and concomitantly multiviral binding. Thus, whereas previous work npg a r t i c l e s had suggested that RhTC has evolved a new active site, we have found it has actually evolved an active site capable of many different conforma tions. This conformational plasticity appears to be an intrinsic prop erty as an open conformation can be formed in the absence of HIV2, whereas a closed conformation must be populated in the free state for it to be fixed in the disulfide bridge experiment. Such an interpretation is supported by the NMR data, which show that residues within the loop are highly mobile. Of course this does not rule out the possibility that induced fit also plays a role, and it is likely that upon binding of capsid protein some alteration in the RhTC structure occurs.
Viruses are known to evolve extremely rapidly and, as a consequence, evade recognition by the immune system. This presents two funda mental problems for the innate immune response. First, it must be able to deal with many different strains of the same virus. Second, it must have a way of countering the rapid emergence of new strains. The adap tive immune system solves both problems genetically by recombining receptors from a library of gene fragments and somatically evolving them during an infection. In contrast, innate effector proteins are not produced by random recombination, and their evolution, being genera tional, is orders of magnitude slower. Our findings suggest that innate antivirals can augment their lack of genetic diversity with diversity of protein structure. RhTC uses its conformational diversity to expand the repertoire of viruses it can target. Furthermore, the fact that RhTC can target multiple viruses suggests that there can be selection pressure by more than one virus at any one time. The fact that some viruses, such as HIV1 M group, are not susceptible suggests that there is also selec tion pressure on the virus to escape. We cannot know the identity of the viruses that have placed RhTC under selection in evolutionary history, and therefore, it is intriguing that although Mgroup viruses escape RhTC, they have not been found in studied macaque populations.
Our data illustrate how conformational diversity can be used to expand antiviral function. Additional work is required to deter mine whether this strategy is used by other innate antivirals, such as TRIM5α. TRIM5α binds to viral capsids using its PRYSPRY domain, a βsandwich fold with a binding site comprising six flexible loops. We speculate that adoption of alternative loop conformations may explain why TRIM5α is able to restrict diverse viruses, including lentiviruses and gammaretroviruses 1, [16] [17] [18] as well as betaretroviruses 19 and even the very distantly related spumaviruses 20 . Conformational diversity of TRIM5α may complement the mechanism by which this and related antivirals directly contact the viral capsid. Recent data have shown that TRIM5α forms a lattice across the capsid, suggesting that apparent affinity may be increased through avidity 21 . This manner of binding could compensate for the entropic cost associated with the stabiliza tion of a single conformer upon ligand binding. In a general context, our data provide an example of how a single gene does not necessarily give rise to a single protein with a single conformation, but rather to multiple conformations, each of which can bind a different target.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/nsmb/. 
